Azilsartan as “Add-On” Treatment with Methotrexate Improves the Disease Activity of Rheumatoid Arthritis

Table 6

Effect of azilsartan (Azil) on the liver and kidney function markers of patients with active RA maintained on methotrexate (MTX).

Parameters	MTX + placebo		MTX + Azil
	Baseline	After 90 days	Baseline	After 90 days
Serum AST (U/L)
Serum ALT (U/L)
Serum creatinine (mg/dl)
Serum urea (mg/dl)

Values were presented as mean ± S.D; : number of patients; different compared with baseline within the same group ; values with different superscripts (a, b, and c) within each parameter were significantly different .